South Israel Bridging Fund
VC Fund
Be'er Sheva, Israel
South Israel Bridging Fund is a venture capital firm.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 32%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries South Israel Bridging Fund invests in
BiotechnologySoftwareEnergyFinTechMachine Learning
Stages South Israel Bridging Fund invests in
Series AVenture - Series UnknownSeries BSeedFunding Round
Countries South Israel Bridging Fund invests in
IsraelCyprusUnited States
Round sizes
Series A $1.5M–$34MSeries B $7M–$8.1MVenture - Series Unknown $750k–$2M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.5M–$34M
- Series B
- $7M–$8.1M
- Venture - Series Unknown
- $750k–$2M
Investment Focus
Industry
- Biotechnology 6 (27%)
- Software 5 (23%)
- Energy 3 (14%)
- FinTech 3 (14%)
- Machine Learning 3 (14%)
Stage
- Series A 7 (32%)
- Venture - Series Unknown 5 (23%)
- Series B 4 (18%)
- Seed 3 (14%)
- Funding Round 2 (9%)
Country
- Israel 20 (91%)
- Cyprus 1 (5%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Boaz Or-Shraga
General Partner
|
General Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gadfin
|
Gadfin design and develops long-range Urgent-delivery systems of the future, which is no less than a game-changer for the Medical and Time-critical deliveries market. Its system brings together traditional flight knowledge, unmanned and autonomy technology, thus redefining delivery capabilities in terms of flight radius, safety, reliability, andautomation, that is going to disrupt the world. | $7M / Series A / May 04, 2022 | |
Stargo
|
Founded in 2010, Stargo is a private company that aims to revolutionize the freight forwarding and supply chain industry by automating and optimizing routing and pricing in real-time in seconds.Using our Decision Support System (DSS) with extensive artificial intelligence capabilities, we offer dynamic optimized pricing and guaranteed payment(through a global banking network), maximizing the efficiency of the cargo shipping quote generation process and eliminating negative working capital on successful quotes.We use proprietary cloud-based big data, machine learning and optimization engines to optimize prices from tens of thousands of global carriers, as they rapidly change. Our artificially intelligent engine is the one way to make sense of the time-consuming and labor-intensive traditional pricing practices. Our vision is to see the freight forwarding, shipping and logistics industries experience a digital transformation, making them epically more efficient, profitable, reliable and robust. | $12M / Series C / Mar 17, 2022 | |
Electriq Global
|
Electriq~Global is a renewable and environment company that features water-based fuel designed for cars, trucks, bikes, buses, and generators. Its specializes in separating the hydrogen from water as an alternative for fuel. The company was founded in 2014 by Alex Silverman and is headquartered in Hefa, Israel. | $7M / Series B / Feb 21, 2022 | |
FortePhest
|
Founded in 2017, FortePhest is a biotechnology company focusing on crop protection. The Company develops innovative products to control both regular weeds and weeds which are resistant to herbicides. They do this mainly by exploring novel Mechanisms of Action (MOA) discovered in plants. Inspired by natural plant protectors, our products areintended to provide potent, environmentally friendly, and sustainable solutions that may eventually improve crop productivity. Our technology is based on research of world-class teams of scientists from Cornell University, The Weizmann Institute of Science and the Hebrew University of Jerusalem. | Series B / Feb 10, 2022 | |
GetPackage
|
GetPackage has developed a tech platform for last-mile delivery industry. The company innovative solution reduces the delivery times and costs while increasing courier’s compensations. This is enabled by a unique technology which evaluates and generate optimize dynamic routes for sharing economy couriers with full or part-time activity. | $3M / Series A / Jan 03, 2022 | |
Synvertec
|
Synvertec is an Israeli based company established in 2014. Utilizing innovative patented technology developed at Tel Aviv University, Synvertec helps facilitate high levels of Renewable Energy Sources (RES) and Distributed Energy Resources (DER) within diverse electricity grids, while also significantly enhancing grid stability. Synvertecdeveloped the Synchronverter®, a patented control algorithm that interacts with inverter switches and emulates the mechanical and electrical properties of a synchronous generator. The Synchronverter® transforms renewable energy inverters into cutting-edge grid stabilizing devices. With the addition of the Synchronverter® , inverters play an active role in the stabilization of grids whose considerable renewable energy source (RES) proportions would otherwise create significant instability. Synvertec's funders include a leading seed investment alliance (Horizon Green Tech Ventures), the Israeli government (OCS), and Israel Electric Company (IEC - Israeli Grid Operator). Synvertec is also a proud participant in Horizon 2020, the European Commission's largest research and innovation program. | $750K / Venture - Series Unknown / Oct 31, 2021 | |
Beta-O2 Technologies
|
Beta-O2 Technologies Ltd. is a biomedical company, developing a proprietary implantable bioreactor, the ßAir, for the treatment of patients with type 1diabetes (T1D). ßAir was developed to address the main problems of the otherwise successful procedure in which islets of Langerhans (i.e. pancreatic endocrine cells) are transplanted in diabeticpatients, such as the need for life-long immunosuppressive pharmacological treatment and deterioration of functionality the transplanted islets over time due to insufficient oxygen supply. It is a small medical device, which is implanted in a minimally invasive procedure. The islet-cell-containing device is planned to provide patients with freedom from insulin injections and repeated monitoring of glucose levels. This innovative device also reduces the risk for hypoglycemic episodes as well as diabetes complications. ßAir provides very effective protection from the host immune system, thus eliminating the need for immunosuppressive therapy and preventing what could otherwise be a fatal immune response of the patient to the transplanted cells. | $1M / Venture - Series Unknown / Sep 09, 2021 | |
SIGA OT Solutions
|
SIGA, develops the "SigaPlatform" ,a comprehensive process anomaly detection system that monitors critical assets using electrical signal-based predictive analysis and artificial intelligence. It cannot be hacked or manipulated from the operational network and it can be used to maintenance and operational needs as well as forcyber-security. | $8.1M / Series B / Aug 09, 2021 | |
Solight
|
Solight is developing an innovative, efficient, and affordable static solar lighting system.The Solight system collects sunlight throughout the day and effectively channels it into desired spaces, as natural, healthy, full spectrum, interior lighting.Solight participated in the Innovation Authorities’ Incubator Program from March 2014. TillSeptember 2016, our notable business partners at the ATI Incubator, included GE, Rotem Industries and Gefen Biomed, all incorporated under Horizon GreenTech Ventures. Having won the European Union’s Prestigious Horizon 2020 SME Phase II programme, Solight commenced its project under this excellent funding structure to realize the following goals: preparing the SOLIS system for client Beta installations with the main points being: cost-reduction, industrialization and stringent real-world testing under diverse conditions. | $1M / Venture - Series Unknown / Aug 02, 2021 | |
BridgerPay
|
We’re solving the toughest payment challenges to deliver growth-ready payment infrastructure. | $6M / Seed / Jul 22, 2021 | |
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
FinTech Investors
43,106 investors
Artificial intelligence Investors
40,702 investors
Energy Investors
25,111 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Machine Learning Investors
17,935 investors
SaaS VC Funds
61,208 investors
FAQ
What does South Israel Bridging Fund invest in?
South Israel Bridging Fund invests primarily in Biotechnology, Software and Energy startups, most often at Series A and Venture - Series Unknown stage. Most of the 22 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is South Israel Bridging Fund's check size?
South Israel Bridging Fund typically joins rounds of $1.5M–$34M at Series A, $7M–$8.1M at Series B and $750k–$2M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds South Israel Bridging Fund participates in.
How do I contact South Israel Bridging Fund?
Public channels for South Israel Bridging Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at South Israel Bridging Fund?
The team at South Israel Bridging Fund includes Boaz Or-Shraga (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
